Build status - In Progress

Study to Test Tecovirimat for the Treatment of Human Monkeypox Virus Disease

Recruiting
18 years - 99 years
All
25 participants needed
1 Location

Brief description of study

The study is testing a drug called, Tecovirimat, which is being tested to see if it works to treat human Monkeypox virus infection and if the study drug is safe in people. Participants in the study will take the tablets twice every day for two weeks and be checked by study nurses and study doctors. Study includes at least 6 clinical visits. Study duration is 2 months.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Monkeypox Virus
  • Age: 18 years - 99 years
  • Gender: All
Updated on 04 Aug 2024. Study ID: 852078

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center